Copyright Reports & Markets. All rights reserved.

Global Galectin 3 Market Research Report 2020, Forecast to 2025

Buy now

Table of Contents

    Global Galectin 3 Market Research Report 2020, Forecast to 2025

      1 Market Overview

      • 1.1 Galectin 3 Definition
        • 1.1.1 Analysis of Macroeconomic Indicators
        • 1.1.2 Years Considered
      • 1.2 Galectin 3 Segment by Type
        • 1.2.1 GAL-300
        • 1.2.2 GRMD-03
        • 1.2.3 ANG-4021
        • 1.2.4 KTI
        • 1.2.5 Others
      • 1.3 Market Analysis by Application
        • 1.3.1 Liver Cirrhosis
        • 1.3.2 Portal Hypertension
        • 1.3.3 Metastatic Melanoma
        • 1.3.4 Others
      • 1.4 Overview of Global Galectin 3 Market
        • 1.4.1 Global Galectin 3 Revenue (2015-2025)
        • 1.4.2 Global Galectin 3 Production and Capacity (2015-2025)
        • 1.4.3 North America Galectin 3 Status and Prospect (2015-2025)
        • 1.4.4 Europe Galectin 3 Status and Prospect (2015-2025)
        • 1.4.5 Japan Galectin 3 Status and Prospect (2014-2025)
        • 1.4.6 China Galectin 3 Status and Prospect (2015-2025)
      • 1.5 Market Dynamics
        • 1.5.1 Market Opportunities
        • 1.5.2 Market Risk
        • 1.5.3 Market Driving Force
        • 1.5.4 Porter's Five Forces Analysis
        • 1.5.5 SWOT Analysis
      • 1.6 Coronavirus Disease 2019 (Covid-19): Galectin 3 Industry Impact
        • 1.6.1 How the Covid-19 is Affecting the Galectin 3 Industry
        • 1.6.2 Galectin 3 Business Impact Assessment - Covid-19
        • 1.6.3 Market Trends and Galectin 3 Potential Opportunities in the COVID-19 Landscape
        • 1.6.4 Measures / Proposal against Covid-19

      2 Global Galectin 3 Market Competition by Manufacturer

      • 2.1 Global Galectin 3 Sales and Market Share by Manufacturer (2018-2020)
      • 2.2 Global Galectin 3 Revenue and Market Share by Manufacturer (2018-2020)
      • 2.3 Global Galectin 3 Industry Concentration Ratio (CR5 and HHI)
      • 2.4 Top 5 Galectin 3 Manufacturer Market Share
      • 2.5 Top 10 Galectin 3 Manufacturer Market Share
      • 2.6 Date of Key Manufacturers Enter into Galectin 3 Market
      • 2.7 Key Manufacturers Galectin 3 Product Offered
      • 2.8 Mergers & Acquisitions Planning

      3 Analysis of Galectin 3 Industry Key Manufacturers

      • 3.1 Angion Biomedica Corp
        • 3.1.1 Company Details
        • 3.1.2 Product Information
        • 3.1.3 Angion Biomedica Corp Galectin 3 Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
        • 3.1.4 Main Business Overview
        • 3.1.5 Angion Biomedica Corp News
      • 3.2 Bristol-Myers Squibb Company
        • 3.2.1 Company Details
        • 3.2.2 Product Information
        • 3.2.3 Bristol-Myers Squibb Company Galectin 3 Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
        • 3.2.4 Main Business Overview
        • 3.2.5 Bristol-Myers Squibb Company News
      • 3.3 Galectin Therapeutics Inc
        • 3.3.1 Company Details
        • 3.3.2 Product Information
        • 3.3.3 Galectin Therapeutics Inc Galectin 3 Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
        • 3.3.4 Main Business Overview
        • 3.3.5 Galectin Therapeutics Inc News
      • 3.4 GlycoMimetics Inc
        • 3.4.1 Company Details
        • 3.4.2 Product Information
        • 3.4.3 GlycoMimetics Inc Galectin 3 Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
        • 3.4.4 Main Business Overview
        • 3.4.5 GlycoMimetics Inc News
      • 3.5 iTeos Therapeutics SA
        • 3.5.1 Company Details
        • 3.5.2 Product Information
        • 3.5.3 iTeos Therapeutics SA Galectin 3 Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
        • 3.5.4 Main Business Overview
        • 3.5.5 iTeos Therapeutics SA News
      • 3.6 MandalMed Inc
        • 3.6.1 Company Details
        • 3.6.2 Product Information
        • 3.6.3 MandalMed Inc Galectin 3 Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
        • 3.6.4 Main Business Overview
        • 3.6.5 MandalMed Inc News

      4 Global Galectin 3 Market Size Categorized by Regions (2015-2020)

      • 4.1 Global Galectin 3 Sales Market Share by Region
      • 4.2 Global Galectin 3 Revenue Market Share by Region (2015-2019)
      • 4.3 Global Galectin 3 Sales, Revenue, Price and Gross Margin (2015-2020)
      • 4.4 North America Galectin 3 Market Size Detail
        • 4.4.1 North America Galectin 3 Sales Growth Rate (2015-2020)
        • 4.4.2 North America Galectin 3 Sales, Revenue, Price and Gross Margin (2015-2020)
      • 4.5 Europe Galectin 3 Market Size Detail
        • 4.5.1 Europe Galectin 3 Sales Growth Rate (2015-2020)
        • 4.5.2 Europe Galectin 3 Sales, Revenue, Price and Gross Margin (2015-2020)
      • 4.6 Japan Galectin 3 Market Size Detail
        • 4.6.1 Japan Galectin 3 Sales Growth Rate (2015-2020)
        • 4.6.2 Japan Galectin 3 Sales, Revenue, Price and Gross Margin (2015-2020)
      • 4.7 China Galectin 3 Market Size Detail
        • 4.7.1 China Galectin 3 Sales Growth Rate (2015-2020)
        • 4.7.2 China Galectin 3 Sales, Revenue, Price and Gross Margin (2015-2020)

      5 Global Galectin 3 Market Segment by Type

      • 5.1 Global Galectin 3 Revenue, Sales and Market Share by Type (2015-2020)
        • 5.1.1 Global Galectin 3 Sales and Market Share by Type (2015-2020)
        • 5.1.2 Global Galectin 3 Revenue and Market Share by Type (2015-2020)
      • 5.2 GAL-300 Sales Growth Rate and Price
        • 5.2.1 Global GAL-300 Sales Growth Rate (2015-2020)
        • 5.2.2 Global GAL-300 Price (2015-2020)
      • 5.3 GRMD-03 Sales Growth Rate and Price
        • 5.3.1 Global GRMD-03 Sales Growth Rate (2015-2020)
        • 5.3.2 Global GRMD-03 Price (2015-2020)
      • 5.4 ANG-4021 Sales Growth Rate and Price
        • 5.4.1 Global ANG-4021 Sales Growth Rate (2015-2020)
        • 5.4.2 Global ANG-4021 Price (2015-2020)
      • 5.5 KTI Sales Growth Rate and Price
        • 5.5.1 Global KTI Sales Growth Rate (2015-2020)
        • 5.5.2 Global KTI Price (2015-2020)
      • 5.6 Others Sales Growth Rate and Price
        • 5.6.1 Global Others Sales Growth Rate (2015-2020)
        • 5.6.2 Global Others Price (2015-2020)

      6 Global Galectin 3 Market Segment by Application

      • 6.1 Global Galectin 3 Sales Market Share by Application (2015-2020)
      • 6.2 Liver Cirrhosis Sales Growth Rate (2015-2020)
      • 6.3 Portal Hypertension Sales Growth Rate (2015-2020)
      • 6.4 Metastatic Melanoma Sales Growth Rate (2015-2020)
      • 6.5 Others Sales Growth Rate (2015-2020)

      7 Galectin 3 Related Market Analysis

      • 7.1 Upstream Analysis
        • 7.1.1 Macro Analysis of Upstream Markets
        • 7.1.2 Key Players in Upstream Markets
        • 7.1.3 Upstream Market Trend Analysis
        • 7.1.4 Galectin 3 Manufacturing Cost Analysis
      • 7.2 Downstream Market Analysis
        • 7.2.1 Macro Analysis of Down Markets
        • 7.2.2 Key Players in Down Markets
        • 7.2.3 Downstream Market Trend Analysis
        • 7.2.4 Sales Channel, Distributors, Traders and Dealers

      8 Global Galectin 3 Market Forecast

      • 8.1 Global Galectin 3 Sales, Revenue Forecast
        • 8.1.1 Global Galectin 3 Sales Growth Rate Forecast (2020-2025)
        • 8.1.2 Global Galectin 3 Revenue and Growth Rate Forecast (2020-2025)
        • 8.1.3 Global Galectin 3 Price and Trend Forecast (2020-2025)
      • 8.2 Global Galectin 3 Sales Forecast by Region (2020-2025)
        • 8.2.1 North America Galectin 3 Sales, Revenue Forecast (2020-2025)
        • 8.2.2 Europe Galectin 3 Sales, Revenue Forecast (2020-2025)
        • 8.2.3 Japan Galectin 3 Production, Revenue Forecast (2020-2025)
        • 8.2.4 China Galectin 3 Production, Revenue Forecast (2020-2025)

      9 Research Findings and Conclusion

        10 Appendix

        The report forecast global Galectin 3 market to grow to reach xx Million USD in 2020 with a CAGR of xx% during the period of 2020-2025. Projected and forecast revenue values are in constant U.S. dollars, unadjusted for inflation. Product values are estimated based on manufacturers' revenue. Estimates of the regional markets for Galectin 3 are based on the applications market.

        The report demonstrates detail coverage of Galectin 3 industry and main market trends.
        The market research includes historical and forecast data, like demand, application details, price trends, and company shares of the leading Galectin 3 by geography, especially focuses on the key regions like United States, European Union, China, and other regions.
        Since the COVID-19 virus outbreak in December 2019, the World Health Organization declared it a public health emergency. The desease has spread to over 100 countries and caused huge losses of lives around the globe. Especially the global manufacturing, tourism and financial markets have been hit hard. The downward pressure on the world economy that once showed signs of recovery in the previous period has increased again. The outbreak of the epidemic has added risk factors to the already weak growth of the world economy. Many international organizations have pointed out that the world economy is in the most severe period since the financial crisis.
        The negative global impacts of the coronavirus are already there, significantly affecting the Galectin 3 market in 2020. This report studies and analyzes the in-depth impact of Coronavirus COVID-19 on the Galectin 3 industry.
        In addition, the report provides insight into main drivers of market demand and strategies of suppliers. Key players are profiled, and their market shares in the global Galectin 3 market are discussed. And this report covers the historical situation, present status and the future prospects of the global Galectin 3 market for 2015-2025.

        Market Segment by Product Type
        GAL-300
        GRMD-03
        ANG-4021
        KTI
        Others

        Market Segment by Product Application
        Liver Cirrhosis
        Portal Hypertension
        Metastatic Melanoma
        Others

        Finally, the report provides detailed profile and data information analysis of leading company.
        Angion Biomedica Corp
        Bristol-Myers Squibb Company
        Galectin Therapeutics Inc
        GlycoMimetics Inc
        iTeos Therapeutics SA
        MandalMed Inc

        Report Includes:
        - xx data tables (appendix tables)
        - Overview of global Galectin 3 market
        - An detailed key players analysis across regions
        - Analyses of global market trends, with historical data, estimates for 2020 and projections of compound annual growth rates (CAGRs) through 2025
        - Insights into regulatory and environmental developments
        - Information on the supply and demand scenario and evaluation of technological and investment opportunities in the Galectin 3 market
        - Profiles of major players in the industry, including Angion Biomedica Corp, Bristol-Myers Squibb Company, Galectin Therapeutics Inc, GlycoMimetics Inc, iTeos Therapeutics SA.....

        Research Objectives
        1.To study and analyze the global Galectin 3 consumption (value & volume) by key regions/countries, product type and application, history data from 2015 to 2019, and forecast to 2025.
        2.To understand the structure of Galectin 3 market by identifying its various subsegments.
        3.Focuses on the key global Galectin 3 manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, Porter's five forces analysis, SWOT analysis and development plans in next few years.
        4.To analyze the Galectin 3 with respect to individual growth trends, future prospects, and their contribution to the total market.
        5.To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
        6.To project the consumption of Galectin 3 submarkets, with respect to key regions (along with their respective key countries).
        7.To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
        8.To strategically profile the key players and comprehensively analyze their growth strategies.

        Buy now